EP3718565
BÓLUEFNI GEGN VEIRUSÝKINGUM Í ÖNDUNARFÆRUM
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
21.10.2016EP published:
27.4.2022EP application number:
20164728.6
EP translation filed:
27.5.2022Grant published:
15.7.2022EPO information:
European Patent Register
Max expiry date:
20.10.2036Expiry date:
20.10.2026Next due date:
31.10.2026
Title in English:
RESPIRATORY VIRUS VACCINESLanguage of the patent:
English
Timeline
Today
21.10.2016EP application
27.4.2022EP Publication
27.5.2022Translation submitted
15.7.2022Registration published
20.10.2026Expires
Owner
Name:
ModernaTX, Inc.Address:
200 Technology Square, Cambridge, MA 02139, US
Inventor
Name:
CIARAMELLA,, GiuseppeAddress:
Sudbury, MA 01776, US
Name:
HIMANSU,, SunnyAddress:
Winchester, MA 01890, US
Agent
Name:
Budde Schou A/SAddress:
Dronningens Tværgade 30, DK
Priority
Number:
201562245031 PDate:
22.10.2015Country:
US
Number:
201562244813 PDate:
22.10.2015Country:
US
Number:
201562244946 PDate:
22.10.2015Country:
US
Number:
201562244802 PDate:
22.10.2015Country:
US
Number:
201562244837 PDate:
22.10.2015Country:
US
Number:
201562247362 PDate:
28.10.2015Country:
US
Number:
201562247483 PDate:
28.10.2015Country:
US
Number:
201562247394 PDate:
28.10.2015Country:
US
Number:
201562247297 PDate:
28.10.2015Country:
US
Classification
Categories:
A61K 39/12, A61P 11/00, C07K 16/10
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 7.9.2022
Expires: 20.10.2023
Payer: Árnason Faktor ehf.
Number: 8
Paid: 13.10.2023
Expires: 20.10.2024
Payer: Árnason Faktor ehf.
Number: 9
Paid: 17.9.2024
Expires: 20.10.2025
Payer: Árnason Faktor ehf.
Number: 10
Paid: 22.10.2025
Expires: 20.10.2026
Payer: Árnason Faktor ehf.